Studies have demonstrated that concentration of ccf-DNA elevates in patients with lung cancer, breast cancer, gastric cancer, colorectal cancer, urologic tumor, head and neck tumor, etc. [17]. This evidence concerns the gene PITX1 and breast cancer.